EHA 2020 | Impact of COVID-19 on AML treatment & management

Name: Impact of COVID-19 on AML treatment & management
Uploaded: 2020-06-11T00:00:00Z
Duration: 3 min 16 s
Description: Thomas Prebet, MD, of the Yale School of Medicine, New Haven, CT, evaluates the impact of the COVID-19 pandemic on the treatment and management of acute myeloid leukemia (AML) patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Thomas Prebet • 11 Jun 2020

EHA 2020

Acute Myeloid Leukemia Leukemia

Thomas Prebet, MD, of the Yale School of Medicine, New Haven, CT, evaluates the impact of the COVID-19 pandemic on the treatment and management of acute myeloid leukemia (AML) patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).